טיפול משולב עם נוגדן נגד ang2 ואגוניסט של cd40
- 专利权人:
- F. HOFFMANN-LA ROCHE AG
- 发明人:
- 申请号：
- IL24445416
- 公开号：
- IL244454D0
- 申请日:
- 2016.03.06
- 申请国别(地区):
- IL
- 年份:
- 2016
- 代理人:
- 摘要：
- The present invention relates to the combination therapy of an antibodies that binds to human angiopoietin 2 (ANG-2) with a CD40 agonist.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINED THERAPY USING AN ANTIBODY TO ANG2 AND AGONIST CD40
- COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
- COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
- Combination therapy with an anti-ANG2 antibody and a CD40 agonist
- COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
